Watch CBS News

Johnson & Johnson Close To Release Of Their COVID-19 Vaccine

(CBS Detroit) - Researchers say Johnson and Johnson's coronavirus vaccine generates a durable immune response with minimal side effects.

That's according to a study in the New England journal of medicine.

Unlike the Pfizer and Moderna vaccines currently being given, only one dose is needed to provide enough protection from COVID-19.

Johnson & Johnson is expected to apply for emergency use authorization from the FDA within the next few weeks.

© 2021 CBS Broadcasting Inc. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.

View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.